Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T17:06:37.741Z.
Calculation as of: 2026-10-06T17:06:37.741Z.
Quote observation: 2026-10-06T17:05:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6dae1ed753b385efcb651dd8f32a10b6f9886011747f410ddce9f57bee9a14c9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Dianthus Therapeutics, Inc.
Market Cap
$4.68B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Price/OCF Ratio
21.48
TTM Avg
18.81
3Y Avg
169.88
5Y Avg
191.97
Market Cap
$4.66B
Price/OCF Ratio
13.43
TTM Avg
16.00
3Y Avg
16.81
5Y Avg
18.87
Market Cap
$4.65B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Price/OCF Ratio
103.08
TTM Avg
302.47
3Y Avg
302.47
5Y Avg
302.47
Market Cap
$4.83B
Price/OCF Ratio
N/A
TTM Avg
198.10
3Y Avg
199.02
5Y Avg
199.02
Market Cap
$4.44B
Price/OCF Ratio
N/A
TTM Avg
17.21
3Y Avg
17.21
5Y Avg
17.21
Market Cap
$4.42B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.68B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 21.48 | 18.81 | 169.88 | 191.97 |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 13.43 | 16.00 | 16.81 | 18.87 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.65B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.68B | 103.08 | 302.47 | 302.47 | 302.47 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.81B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | N/A | 198.10 | 199.02 | 199.02 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.44B | N/A | 17.21 | 17.21 | 17.21 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.42B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.40B | N/A | 17.89 | 33.70 | 30.73 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
